Mahnke, C, Kashaiya, P, Rössler, J et al. · Archives of virology · 1992 · DOI
Researchers tested blood samples from over 3,000 people in Africa and Europe to look for antibodies to a virus called human spumavirus. They found that about 3% of people worldwide had signs of this virus in their blood, but in African patients the rate was much higher at 6.3%. Notably, patients with ME/CFS, multiple sclerosis, and Graves' disease showed very low or no evidence of this virus.
This study examined whether human spumavirus—a retrovirus with uncertain pathogenic role—might be associated with ME/CFS and other chronic conditions. The finding that ME/CFS patients showed no or very low spumavirus seropositivity argues against this particular viral agent as a common contributor to ME/CFS pathogenesis, helping to refocus research attention on other potential infectious or post-infectious mechanisms.
This study does not prove that spumavirus plays no role in any individual ME/CFS case, nor does it demonstrate that absence of seropositivity rules out past infection or reactivation. The cross-sectional design captures only a single time point and cannot establish causality or temporal relationships between viral exposure and disease onset.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.